Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 29:1512-1517, 2006
DOI: 10.2337/dc05-2315
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yates, K.
Right arrow Articles by Ambler, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yates, K.
Right arrow Articles by Ambler, G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Emerging Treatments and Technologies
Original Article

Continuous Glucose Monitoring–Guided Insulin Adjustment in Children and Adolescents on Near-Physiological Insulin Regimens

A randomized controlled trial

Kylie Yates, MBBS, FRACP1, Abul Hasnat Milton, PHD2, Keith Dear, PHD3 and Geoffrey Ambler, MD, FRACP1

1 Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Westmead, NSW, Australia
2 Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, Australia
3 National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia

Address correspondence and reprint requests to Kylie Yates, MBBS, FRACP, Institute of EndocrinologyDiabetes, The Children’s Hospital, Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. E-mail: kyliey{at}chw.edu.au

OBJECTIVE—This randomized controlled trial assesses the effect on glycemic control of continuous glucose monitoring system (CGMS)-guided insulin therapy adjustment in young people with type 1 diabetes on intensive diabetes treatment regimens with continuous subcutaneous insulin infusion (CSII) or glargine.

RESEARCH DESIGN AND METHODS—Pediatric subjects were recruited if they had an HbA1c (A1C) <10% and had been on CSII or glargine for at least 3 months. Thirty-six subjects were randomized to insulin adjustment on the basis of 72 h of CGMS every 3 weeks or intermittent self-monitoring of blood glucose (SMBG) for 3 months. A1C and fructosamine were measured at baseline and 6 and 12 weeks. Follow-up A1C was measured at 6 months. Mean baseline A1C was 8.2% (n = 19) in the CGMS group and 7.9% (n = 17) in the control group.

RESULTS—There was a significant improvement in A1C from baseline values in both groups, but there was no difference in the degree of improvement in A1C at 12 weeks between the CGMS (–0.4% [95% CI –0.7 to –0.1]) and the control group (–0.4% [–0.8 to 0.2]). In the CGMS group, improved A1C was at the cost of increased duration of hypoglycemia.

CONCLUSIONS—CGMS is no more useful than intermittent fingerstick SMBG and frequent review in improving diabetes control in reasonably well-controlled patients on near-physiological insulin regimens when used in an outpatient clinic setting.

Abbreviations: BGL, blood glucose level • CGMS, continuous glucose monitoring system • CSII, continuous subcutaneous insulin infusion • MDI, multiple daily doses of insulin • SMBG, self-monitoring of blood glucose


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.